BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8492715)

  • 1. Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: effect of nonesterified fatty acids.
    Walker M; Agius L; Orskov H; Alberti KG
    Metabolism; 1993 May; 42(5):601-8. PubMed ID: 8492715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
    Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG
    Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
    Fulcher GR; Walker M; Farrer M; Johnson AS; Alberti KG
    Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
    Worm D; Henriksen JE; Vaag A; Thye-Rønn P; Melander A; Beck-Nielsen H
    J Clin Endocrinol Metab; 1994 Mar; 78(3):717-21. PubMed ID: 8126147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
    Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.
    Saloranta C; Franssila-Kallunki A; Ekstrand A; Taskinen MR; Groop L
    Diabetologia; 1991 Jun; 34(6):409-15. PubMed ID: 1884899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of changes in plasma nonesterified fatty acid levels on oxidative metabolism during moderate exercise in patients with non-insulin-dependent diabetes mellitus.
    Akanji AO; Osifo E; Kirk M; Hockaday TD
    Metabolism; 1993 Apr; 42(4):426-34. PubMed ID: 8487664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
    Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
    Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of plasma non-esterified fatty acids during exercise in type 2 diabetes mellitus.
    Berrish TS; Elliott C; Cooper BG; Reed JW; Orskov H; Alberti KG; Walker M
    Diabet Med; 1993 Mar; 10(2):152-8. PubMed ID: 8458192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Fulcher GR; Walker M; Catalano C; Farrer M; Alberti KG
    Clin Sci (Lond); 1992 May; 82(5):565-71. PubMed ID: 1317767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of forearm immobilization and acipimox administration on muscle amino acid metabolism and insulin sensitivity in healthy, young volunteers.
    Dirks ML; Jameson TSO; Andrews RC; Dunlop MV; Abdelrahman DR; Murton AJ; Wall BT; Stephens FB
    Am J Physiol Endocrinol Metab; 2024 Mar; 326(3):E277-E289. PubMed ID: 38231001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effect of decreasing nonesterified fatty acid levels with acipimox in hyperthyroid patients.
    Park KS; Kim CH; Lee MK; Shin CS; Park DJ; Kim SY; Cho BY; Lee HK
    Metabolism; 1999 Oct; 48(10):1318-21. PubMed ID: 10535397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man.
    Ekstrand A; Saloranta C; Ahonen J; Grönhagen-Riska C; Groop LC
    Metabolism; 1992 Jul; 41(7):692-7. PubMed ID: 1619986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
    Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG
    Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.
    Puhakainen I; Yki-Järvinen H
    Diabetes; 1993 Dec; 42(12):1694-9. PubMed ID: 8243814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
    Cusi K; Kashyap S; Gastaldelli A; Bajaj M; Cersosimo E
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
    Paolisso G; Tagliamonte MR; Rizzo MR; Gualdiero P; Saccomanno F; Gambardella A; Giugliano D; D'Onofrio F; Howard BV
    Diabetologia; 1998 Oct; 41(10):1127-32. PubMed ID: 9794097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.